Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with melphalan
Related Experiment Videos
American Journal of Hematology
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Safety and feasability of ureteroscopy for pediatric stone, in children under 5 Years (SFUPA 5): A French multicentric study.
Journal of pediatric urology·2023
Stereotactic body radiation therapy for bone oligometastases.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
[Breast cancer radiation therapy: Current questions in 2023].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Characterizing hospital pathways for the care of acquired hemophilia in France using comprehensive national health data.
La Revue de medecine interne·2021
Clinical Experience of Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.
American journal of hematology·2026
Prognostic Impact of FLT3-ITD Allelic Ratio in AML Patients Treated With High-Dose Anthracycline and a FLT3 Inhibitor.
American journal of hematology·2026
Circulating Biomarkers Associated With Hereditary Hemorrhagic Telangiectasia Sensitive to ALK1 Modulation.
American journal of hematology·2026
New Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification.
American journal of hematology·2026
Outcomes of Patients With AL Amyloidosis and End-Stage Renal Disease After Initiation of Therapy.
American journal of hematology·2026